The innovative combination of different biological agents has made it possible to develop a treatment formula in the form of an intravenous infusion, for treating six (6) types of cancer, which are as follows: Ovarian cancer, testicular cancer, breast cancer, prostate cancer, stomach cancer, bladder cancer; The experimental procedure was prepared over the course of 40 months. The formula was tested in comparison with MYLAN's "cisplatin" treatment and TEVA's "5-fluorouracil" treatment. This treatment is favoured over the other treatments on the market because it provokes the cell death procedure in cancer cells for a shorter period than the cell death period when using the other formulae. Also, VITA's formulation provokes "selective" cell apoptosis without major and moderate negative effects. This formula is intended strictly for the pharmaceutical industry.
展开▼